Login to Your Account



Judge Must Still Sign Off

Genzyme Settles Biosurgery Group Lawsuit: $64M Payout

By Randall Osborne


Monday, August 13, 2007
Genzyme Corp.'s longstanding legal dispute with some shareholders over the buyback of Genzyme Biosurgery stock in 2003 will end not with a figurative bang but with a $64 million whimper, if a judge approves an agreement made between the parties. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription